Generic Drug Recall Raises More Questions

Last week’s surprise announcement by the U.S. Food and Drug Administration that a popular generic antidepressant is not equivalent to the original drug also raises concerns doctors and patients have had about other generic versions of common medications. In an about-face, the FDA announced it had notified drug company Teva Pharmaceuticals to stop shipping Budeprion XL 300 milligrams, a copycat of the extended-release antidepressant Wellbutrin XL 300 milligrams, and to remove it from U.S. shelves. The highly unusual decision contradicts …